KERI ENNS: Open Payments
NPI 1417470006 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 19 payments from 7 companies in 2025. Trend: 2023 $538 · 2024 $721 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $251 |
| PFIZER INC. | 2 | $43 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: FARXIGA, QULIPTA, NURTEC ODT, PREVNAR 20, MOUNJARO, Wegovy, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
